Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Iron boost after hip break: could it speed up recovery?

NCT ID NCT07659184

Symptom relief Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether giving iron supplements to older adults (75+) after hip fracture surgery can reduce fatigue and improve recovery. 528 participants will receive either intravenous iron, oral iron pills, or a placebo. The goal is to see if iron helps with energy, mobility, and quality of life during rehabilitation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Iron (ferric derisomaltose and ferrous sulphate)
What this could lead to
If it works, this could lead to a simple, low-cost way to help older people recover better after a hip fracture, with less fatigue and better quality of life.
What could go wrong
This is a Phase 4 trial, so the drugs are already approved, but it's still possible that iron supplements won't significantly improve recovery or could cause side effects like stomach upset.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 528 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

75 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hip fracture (ICD-10 codes: DS720, DS721 and DS722) * Low energy trauma * Age ≥ 75 years * Hemoglobin ≤7.0 mmol/L (11 g/dL) during hospital admission Exclusion Criteria: * Pathological fracture * Periprosthetic fracture * Inability to understand or speak Danish * Dysphagia and thus inability to swallow study medication * Signs of iron overload, hemochromatosis, or hemosiderosis * Liver disease (cirrhosis or hepatitis) and transaminase levels \>3 times upper limit of normal * Known allergy to iron formulations * Severe asthma * Severe hypophosphatemia: \<0.35 mmol/L * Patients already receiving iron supplementation that cannot be paused for the study period * Cognitive impairment that results in either memantine-treatment or a Short Portable Mental Status Questionnaire (SPMSQ) score \> 4

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anemia Fatigue hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anemia Hip fracture IRON Placebo - control

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aarhus Univeristy Hospital

    Aarhus N, 8200, Denmark

  • Regional Hospital Gødstrup

    Herning, 7400, Denmark

  • Regional Hospital Horsens

    Horsens, 8700, Denmark

  • Regional Hospital Randers

    Randers, 8930, Denmark

  • Regional Hospital Viborg

    Viborg, 8800, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.